Predictors of Improvement after Cognitive Training in Mild Cognitive Impairment: Insights from the Cognitive Training and Neuroplasticity in Mild Cognitive Impairment Trial
- PMID: 39099327
- DOI: 10.1097/WAD.0000000000000639
Predictors of Improvement after Cognitive Training in Mild Cognitive Impairment: Insights from the Cognitive Training and Neuroplasticity in Mild Cognitive Impairment Trial
Abstract
Objective: Cognitive training may benefit older adults with mild cognitive impairment (MCI), but the prognostic factors are not well-established.
Methods: This study analyzed data from a 78-week trial with 107 participants with MCI, comparing computerized cognitive training (CCT) and computerized crossword puzzle training (CPT). Outcomes were changes in cognitive and functional measures from baseline. Linear mixed-effect models were used to identify prognostic factors for each intervention.
Results: Baseline neuropsychological composite z-score was positively associated with cognitive and functional improvements for both interventions in univariable models, retaining significance in the final multivariable model for functional outcome in CPT ( P < 0.001). Apolipoprotein E e4 carriers had worse cognitive ( P = 0.023) and functional ( P = 0.001) outcomes than noncarriers for CPT but not CCT. African Americans showed greater functional improvements than non-African Americans in both CPT ( P = 0.001) and CCT ( P = 0.010). Better baseline odor identification was correlated with cognitive improvements in CPT ( P = 0.006) and functional improvements in CCT ( P < 0.001).
Conclusion: Baseline cognitive test performance, African American background, and odor identification ability are potential prognostic factors for improved outcomes with cognitive interventions in older adults with MCI. Apolipoprotein E e4 is associated with poor outcomes. Replication of these findings may improve the selection of cognitive interventions for individuals with MCI.
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
M.Q. received research grants from the National Science Foundation and National Institutes of Health (NIH). D.P.D. has received research grants from the National Institutes on Aging and Alzheimer’s Association and has served as a consultant on scientific advisory boards to Acadia, Corium, GSK, TauRx, and a DSMB for BioXcel. P.M.D. has received research grants from the NIH, DARPA, DOD, ONR, Salix, Avanir, Avid, Cure Alzhaimer’s Fund, Karen L. Wrenn Trust, US Highbush Blueberry Council, and Steve Aoki Foundation, and advisory/board fees from Apollo, Clearview, Lumos, Prospira, Keel Digital, Otsuka, Compass, Sermo, Nutricia, UMethod, and Transposon. He is a co-inventor of patents for the diagnosis or treatment of Alzheimer’s disease and a patent for infection detection. Also, owns shares in UMethod, Alzheon, Transposon, and MarvelBiome, the products of which are not discussed here. The remaining authors have received grant support from the NIH and declare no conflicts of interest.
Similar articles
-
Expectancy Does Not Predict 18-month Treatment Outcomes with Cognitive Training in Mild Cognitive Impairment.J Prev Alzheimers Dis. 2024;11(1):71-78. doi: 10.14283/jpad.2023.62. J Prev Alzheimers Dis. 2024. PMID: 38230719 Free PMC article. Clinical Trial.
-
Exploring transfer effects on memory and its neural mechanisms through a computerized cognitive training in mild cognitive impairment: randomized controlled trial.Psychogeriatrics. 2024 Sep;24(5):1075-1086. doi: 10.1111/psyg.13161. Epub 2024 Jul 16. Psychogeriatrics. 2024. PMID: 39014538 Free PMC article. Clinical Trial.
-
Effectiveness of a mobile application for independent computerized cognitive training in patients with mild cognitive impairment: study protocol for the NeNaE Study, a randomized controlled trial.Trials. 2024 Jul 3;25(1):444. doi: 10.1186/s13063-024-08277-5. Trials. 2024. PMID: 38961472 Free PMC article.
-
The Efficacy of Cognitive Intervention in Mild Cognitive Impairment (MCI): a Meta-Analysis of Outcomes on Neuropsychological Measures.Neuropsychol Rev. 2017 Dec;27(4):440-484. doi: 10.1007/s11065-017-9363-3. Epub 2017 Dec 27. Neuropsychol Rev. 2017. PMID: 29282641 Free PMC article.
-
[Efficiency of computerized cognitive training for prevention of cognitive impairments and stimulation of neuroplasticity.].Adv Gerontol. 2024;37(3):221-229. Adv Gerontol. 2024. PMID: 39139113 Review. Russian.
Cited by
-
Cognition and Cognitive Training in Patients with Neurodegenerative Diseases.Brain Sci. 2025 Feb 12;15(2):183. doi: 10.3390/brainsci15020183. Brain Sci. 2025. PMID: 40002516 Free PMC article.
References
-
- Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256:183–194.
-
- Evidence profile: cognitive stimulation and training for reducing the risk of cognitive decline and/or dementia. Risk Reduction of Cognitive Decline and Dementia: WHO Guidelines. Geneva: World Health Organization; 2019.
-
- Lustig C, Shah P, Seidler R, et al. Aging, training, and the brain: a review and future directions. Neuropsychol Rev. 2009;19:504–522.
-
- Gates NJ, Rutjes AW, Di Nisio M, et al. Computerised cognitive training for maintaining cognitive function in cognitively healthy people in midlife. Cochrane Database Syst Rev. 2019;3:CD012278.
-
- Hill NT, Mowszowski L, Naismith SL, et al. Computerized cognitive training in older adults with mild cognitive impairment or dementia: a systematic review and meta-analysis. Am J Psychiatry. 2017;174:329–340.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical